MFG
TBIO

Magnus Financial Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Magnus Financial Group’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-70,866
Closed -$707K – 787
2020
Q1 		$707K Hold
70,866
– – 0.1% 103
2019
Q4 		$577K Hold
70,866
– – 0.08% 114
2019
Q3 		$702K Hold
70,866
– – 0.13% 81
2019
Q2 		$895K Buy
+70,866
New +$747K 0.17% 68

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Magnus Financial Group's TBIO Position: Q2 2020 in Review

Magnus Financial Group sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2020, closing a stake of 70,866 shares — an estimated $707K sold.

Magnus Financial Group first reported a position in TBIO in Q2 2019 and held it in 4 quarters. The position peaked at $895K in Q2 2019. 133 funds tracked by Wall St. Rank hold TBIO as of Q2 2020.

  • Magnus Financial Group reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Magnus Financial Group sold 70,866 Translate Bio, Inc. Common Stock shares in Q2 2020, an estimated $707K.
  • Magnus Financial Group first reported a position in Translate Bio, Inc. Common Stock in Q2 2019 and held it in 4 quarters.
  • Magnus Financial Group's Translate Bio, Inc. Common Stock position peaked at $895K in Q2 2019.
  • 133 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2020.

Based on Magnus Financial Group's 13F filing for Q2 2020, filed 11 Aug 2020.